Bessemer Group’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50K Hold
1,428
– – ﹤0.01% 1725
2026
Q2
$29K Buy
+1,428
New +$26.7K ﹤0.01% 1873

Other funds holding TRAX

Bessemer Group's TRAX Position: Q3 2026 in Review

Bessemer Group held its First Tracks Biotherapeutics (TRAX) position steady in Q3 2026 at 1,428 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #1725.

Bessemer Group first reported a position in TRAX in Q2 2026 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • Bessemer Group held 1,428 shares of First Tracks Biotherapeutics worth $50K as of Q3 2026.
  • Bessemer Group left its First Tracks Biotherapeutics share count unchanged in Q3 2026.
  • First Tracks Biotherapeutics made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #1725 holding.
  • Bessemer Group first reported a position in First Tracks Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
  • 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.